Nakagawa M, Koyanagi M, Tanabe K, Takahashi K, Ichisaka T, Aoi T, Okita K, Mochiduki Y, Takizawa N, Yamanaka S (2008) Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts. Mitsui K, Tokuzawa Y, Itoh H, Segawa K, Murakami M, Takahashi K, Maruyama M, Maeda M, Yamanaka S (2003) The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Malynn BA, de Alboran IM, O’Hagan RC, Bronson R, Davidson L, DePinho RA, Alt FW (2000) N-myc can functionally replace c-myc in murine development, cellular growth, and differentiation. Herold S, Wanzel M, Beuger V, Frohme C, Beul D, Hillukkala T, Syvaoja J, Saluz HP, Haenel F, Eilers M (2002) Negative regulation of the mammalian UV response by Myc through association with Miz-1. Hatton KS, Mahon K, Chin L, Chiu FC, Lee HW, Peng D, Morgenbesser SD, Horner J, DePinho RA (1996) Expression and activity of L-Myc in normal mouse development. Gurdon JB, Uehlinger V (1966) “Fertile” intestine nuclei. Annu Rev Genet 20:361–384Ĭole MD, Cowling VH (2008) Transcription-independent functions of MYC: regulation of translation and DNA replication. Nature 450(7173):1230–1234Ĭole MD (1986) The myc oncogene: its role in transformation and differentiation. Mol Cell Biol 15(3):1536–1544Ĭhambers I, Silva J, Colby D, Nichols J, Nijmeijer B, Robertson M, Vrana J, Jones K, Grotewold L, Smith A (2007) Nanog safeguards pluripotency and mediates germline development. Cell 122:947–956īrough DE, Hofmann TJ, Ellwood KB, Townley RA, Cole MD (1995) An essential domain of the c-myc protein interacts with a nuclear factor that is also required for E1A-mediated transformation. Science 251(4998):1211–1217īoyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA (2005) Core transcriptional regulatory circuitry in human embryonic stem cells. Mol Cell Biol 13(9):5216–5224īlackwood EM, Eisenman RN (1991) Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Mol Cell Biol 8(6):2668–2673īlackwell TK, Huang J, Ma A, Kretzner L, Alt FW, Eisenman RN, Weintraub H (1993) Binding of myc proteins to canonical and noncanonical DNA sequences. Mol Cell Biol 12(7):3130–3137īirrer MJ, Segal S, DeGreve JS, Kaye F, Sausville EA, Minna JD (1988) L-myc cooperates with ras to transform primary rat embryo fibroblasts. This process is experimental and the keywords may be updated as the learning algorithm improves.īarrett J, Birrer MJ, Kato GJ, Dosaka-Akita H, Dang CV (1992) Activation domains of L-Myc and c-Myc determine their transforming potencies in rat embryo cells. These keywords were added by machine and not by the authors. The iPS cells generated with L-Myc are safer, of high quality, and therefore are considered to be useful for future clinical applications. Importantly, tumorigenicity is hardly observed in chimeric mice produced with L-Myc iPS cells. L-Myc, one of the Myc family genes, can efficiently generate both mouse and human iPS cells. Although iPS cells can be generated in the absence of c-Myc, the quality of iPS cells seems to be low. However, exogenously expressed c-Myc, especially by retroviruses, causes tumorigenicity in iPSC-derived chimeric mice during long-term observation. c-Myc is one of the original reprogramming factors, and it increases the number of iPS cells generated in both mouse and human systems when it is added to another three factors (Sox2, Oct3/4, and Klf4). 2008 451:141–146.Somatic cells can be reprogrammed into induced pluripotent stem (iPS) cells by the transduction of defined factors. Reprogramming of human somatic cells to pluripotency with defined factors. Park I.H., Zhao R., West J.A., Yabuuchi A., Huo H., Ince T.A. Generation of human induced pluripotent stem cells from dermal fibroblasts. Lowry W.E., Richter L., Yachechko R., Pyle A.D., Tchieu J., Sridharan R. Highly efficient reprogramming to pluripotency and directed differentiation of human cells with synthetic modified mRNA. Warren L., Manos P.D., Ahfeldt T., Loh Y.H., Li H., Lau F. Induced pluripotent stem cell lines derived from human somatic cells. Yu J., Vodyanik M.A., Smuga-Otto K., Antosiewicz-Bourget J., Frane J.L., Tian S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Takahashi K., Tanabe K., Ohnuki M., Narita M., Ichisaka T., Tomoda K.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |